AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,766.00p
   
  • Change Today:
    128.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 4,141,190
  • Market Cap: £166,944m
  • RiskGrade: 123

Latest ShareCast News

EU recommends AstraZeneca bladder cancer treatment for approval

By Benjamin Chiou

Date: Tuesday 27 May 2025

(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).

AstraZeneca ShareCast News

London close: Stocks finish choppy week in the b... 16-May-2025 ShareCast
London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast

AstraZeneca Regulatory News

Block listing Interim Review 02-Jun-2025 15:05 RNS
Total Voting Rights 02-Jun-2025 15:00 RNS
Imfinzi recommended in EU for bladder cancer 27-May-2025 07:00 RNS
Director/PDMR Shareholding 23-May-2025 10:00 RNS
Director Declaration 21-May-2025 13:45 RNS

AstraZeneca Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian
Pfizer unlikely to try AstraZeneca takeover agai... 07-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,766.00p
Change Today 128.00p
% Change 1.20 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 4,141,190
Shares Issued 1,550.66m
Market Cap £166,944m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.61% below the market average93.61% below the market average93.61% below the market average93.61% below the market average93.61% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average12.83% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
61.7% below the market average61.7% below the market average61.7% below the market average61.7% below the market average61.7% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.17% above the market average86.17% above the market average86.17% above the market average86.17% above the market average86.17% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 04-Jun-2025

Time Volume / Share Price
16:14 0 @ 10,778.00p
16:14 0 @ 10,778.00p
16:14 0 @ 10,778.00p
16:17 0 @ 10,774.00p
16:16 1 @ 10,776.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page